Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) shares, rose in value on Wednesday, June 18, with the stock price up by 0.57% to the previous day’s close as strong demand from buyers drove the stock to $12.35.
Actively observing the price movement in the last trading, the stock closed the session at $12.28, falling within a range of $12.1 and $12.96. The value of beta (5-year monthly) was 2.291. Referring to stock’s 52-week performance, its high was $28.17, and the low was $8.04. On the whole, ARCT has fluctuated by 3.00% over the past month.
With the market capitalization of Arcturus Therapeutics Holdings Inc currently standing at about $334.94 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-12.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ARCT’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ARCT currently trading nearly -0.97% and 4.14% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 50.14, while the 7-day volatility ratio is showing 3.67% which for the 30-day chart, stands at 3.99%. Furthermore, Arcturus Therapeutics Holdings Inc (ARCT)’s beta value is 2.29, and its average true range (ATR) is 0.90.
A comparison of Arcturus Therapeutics Holdings Inc (ARCT) with its peers suggests the former has fared considerably weaker in the market. ARCT showed an intraday change of 0.57% in last session, and over the past year, it shrunk by -60.16%%.
Data on historical trading for Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) indicates that the trading volumes over the past 10 days have averaged 0.43 and over the past 3 months, they’ve averaged 443.23K. According to company’s latest data on outstanding shares, there are 27.12 million shares outstanding.
Nearly 8.44% of Arcturus Therapeutics Holdings Inc’s shares belong to company insiders and institutional investors own 91.65% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.5 million shares as on 2025-05-30, resulting in a short ratio of 12.48. According to the data, the short interest in Arcturus Therapeutics Holdings Inc (ARCT) stood at 3140.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 5.14 million. The stock has fallen by -27.22% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ARCT stock heading into the next quarter.
